Broad-Spectrum in-vivo effective superantigen toxin antagonists based on the interaction between CD28 and the superantigen and uses thereof

Details for Australian Patent Application No. 2003219489 (hide)

Owner Yissum Research Development Company of the Hewbrew University of Jerusalem

Inventors Arad, Gila; Kaempfer, Raymond

Agent Davies Collison Cave

Pub. Number AU-B-2003219489

PCT Number PCT/IL03/00278

PCT Pub. Number WO2003/084995

Priority 148993 04.04.02 IL

Filing date 3 April 2003

Wipo publication date 20 October 2003

Acceptance publication date 15 April 2010

International Classifications

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 148993 04.04.02 IL

27 November 2003 Application Open to Public Inspection

  Published as AU-B-2003219489

15 April 2010 Application Accepted

  Published as AU-B-2003219489

12 August 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003219490-ACTIVE LOCAL AREA NETWORK CONNECTOR

2003219488-METHOD AND APPARATUS FOR EFFICIENT TRANSMISSION OF VOIP TRAFFIC